The European Commission grants € 2.5 million to ATRO Medical for the accelerated development of their artificial meniscus. The Dutch startup works on the first anatomical meniscus prostheses for patients with chronic knee pain.
Due to Covid, last year’s winners of the Venture Challenge were announced today at the Dutch Life Sciences Conference. The proud winner of the fall edition is QurieGen, formerly known as Monoceros Analytics. The innovative startup QurieGen has developed a single-cell sequencing-based method to map the changes in transcriptome, membrane and 100’ of intracellular (phospho)proteins simultaneously across multiple pathways (IP filed) to obtain a high-resolution map of cellular response.
Due to Covid, last year’s winners of the Venture Challenge were announced today at the Dutch Life Sciences Conference. The proud winner of the 2021 summer edition is Sella Therapies. The innovative startup Sella Therapies has developed a novel therapy for chronic pain relief that targets the body’s internal neuropeptide system.
Are you still in doubt whether to apply for the venture challenge fall 2022 edition? Perhaps the winner of the last Venture Challenge can pursuade you!
From a scientific idea to a multi-million euro investment: the successes of the many NWO Venture Challenge alumni reveal what can be achieved if you take science out of the lab onto the market.
The proven Venture Challenge coaching programme focuses on developing your initial idea into a solid business case with boot camps, 1-on-1 coaching and mentoring.
Last week five teams started their Venture Challenge adventure. In the first three-day workshop the highly motivated teams worked on their customer value proposition, long-term vision and competitive positioning.